Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €22.09 EUR
Change Today -0.238 / -1.07%
Volume 4.9K
As of 3:25 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

dr hoenle ag (HNL) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/26/15 - €23.99
52 Week Low
08/14/14 - €14.95
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DR HOENLE AG (HNL)

Related News

No related news articles were found.

dr hoenle ag (HNL) Related Businessweek News

No Related Businessweek News Found

dr hoenle ag (HNL) Details

Dr. Hönle AG, together with its subsidiaries, develops, produces, and sells UV radiation systems, lamps, and adhesives and casting compounds for industrial applications worldwide. It operates in three segments: Equipment and Systems, Glass and Lamps, and Adhesives. The company’s products include UV equipment and systems, UV measurement systems, LED units, UV lamps, electronic power supply systems, UV strip/UV scan, and UV adhesives. Its products are used in sheed-fed offset printing, photovoltaic and sun simulation, curing of adhesives and pottants, disinfection, UV measurement technology, UV lamps, fluorescence testing, and inerted systems. The company’s products are also used in inkjet printing, Web offset printing, flexo print, and finishing/coating applications. Dr. Hönle AG was founded in 1976 and is headquartered in Gräfelfing, Germany.

534 Employees
Last Reported Date: 05/22/15
Founded in 1976

dr hoenle ag (HNL) Top Compensated Officers

Chief Financial Officer, Managing Director, D...
Total Annual Compensation: €407.0K
Managing Director of Sales & Technology and M...
Total Annual Compensation: €406.0K
Compensation as of Fiscal Year 2014.

dr hoenle ag (HNL) Key Developments

The Hönle Group Reports Earnings Results for the Six Months of the 2015; Provides Earnings Guidance for 2015

The Hönle Group reported earnings results for the six months of the 2015. For the period, the company reported sales revenues increased by 9.3 % to €44,207,000. At the same time, the operating result (EBIT) surged 55.3 % to €6,013,000. Earnings before tax (EBT) climbed by 58.8 % to €5,763,000 while the consolidated result increased by 58.7 % to €4,324,000. This corresponds to earnings per share of €0.76 compared with €0.49 for the pervious year. Given unchanged general economic conditions, the company management board continues to expect sales of between €85 million and €95 million for the financial year 2014/2015 and an operating result of between €12 million and €14 million.

Dr. Hönle AG Announces Earnings Results for the First Quarter of Fiscal Year 2015; Provides Earnings Guidance for the Year 2015

Dr. Hönle AG announced earnings results for the first quarter of fiscal year 2015. For the quarter, Sales revenues jumped 7.6 % to €21,790,000 and the corporate group succeeded in improving the operating result (EBIT) by 19.6 % to €2,653,000. Earnings before tax rose by 20.2 % to €2,520,000 and consolidated earnings saw a 19.4 % increase to €1,801,000. This translates into earnings per share of €0.32 against €0.28 a year ago. Net profit on sales climbed from 7.5 % to 8.3 % in the same period. The company assumes sales revenues of between €85 and €95 million and an operating result of between €12 and €14 million for the financial year 2015.

Dr. Hönle AG to Report First Half, 2015 Results on May 22, 2015

Dr. Hönle AG announced that they will report first half, 2015 results on May 22, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HNL:GR €22.09 EUR -0.238

HNL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HNL.
View Industry Companies

Industry Analysis


Industry Average

Valuation HNL Industry Range
Price/Earnings 16.7x
Price/Sales 1.5x
Price/Book 2.6x
Price/Cash Flow 12.6x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DR HOENLE AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at